Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Anxiety Disorders
About this trial
This is an interventional treatment trial for Anxiety Disorders focused on measuring Anxiety, antipsychotic
Eligibility Criteria
Inclusion Criteria: Healthy on the basis of physical exam Treatment with one or more allowed antidepressants and/or anxiety medications for at least the past 8 weeks Judgement of the clinician that the patient has shown a sub-optimal response to this treatment Current diagnosis of Generalized Anxiety Disorder Maintained on a stable, therapeutic dose(s) of the allowed medication(s) for at least the past four weeks Exclusion Criteria: Presence of other serious medical illnesses Active use of cocaine or heroin History of suicide attempt in past 12 months Changes to antidepressant/anti-anxiety regimen (medication or dose) within the four weeks preceding study baseline (Day 1) History of clozapine use